Strattera

Product NDC
68151-4485
11-digit product format
681514485
Labeler code
68151
Product ID
68151-4485_14eceffd-5c83-412c-a92c-16242be39f1f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Atomoxetine hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
Carilion Materials Management
Application
NDA021411
Marketing category
NDA
Marketing start
2003-01-10
Marketing end
0000-00-00
Substance
ATOMOXETINE HYDROCHLORIDE
Active strength
18 mg/1
Pharmacologic classes
Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct68151-4485IInactivated by FDA2026-08-03
excluded packagepackage68151-448568151-4485-3IInactivated by FDA2026-08-03

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 8 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021411-001STRATTERAATOMOXETINE HYDROCHLORIDEEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORAL2002-11-26
N021411-002STRATTERAATOMOXETINE HYDROCHLORIDEEQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2002-11-26
N021411-003STRATTERAATOMOXETINE HYDROCHLORIDEEQ 18MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2002-11-26
N021411-004STRATTERAATOMOXETINE HYDROCHLORIDEEQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2002-11-26
N021411-005STRATTERAATOMOXETINE HYDROCHLORIDEEQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2002-11-26
N021411-006STRATTERAATOMOXETINE HYDROCHLORIDEEQ 60MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2002-11-26
N021411-007STRATTERAATOMOXETINE HYDROCHLORIDEEQ 80MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2005-02-14
N021411-008STRATTERAATOMOXETINE HYDROCHLORIDEEQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2005-02-14

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N021411-001STRATTERAEQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORAL2002-11-26a50c72e98297…
2026-08-01 22:54:322026-06N021411-002STRATTERAEQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2002-11-26a50c72e98297…
2026-08-01 22:54:322026-06N021411-003STRATTERAEQ 18MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2002-11-26a50c72e98297…
2026-08-01 22:54:322026-06N021411-004STRATTERAEQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2002-11-26a50c72e98297…
2026-08-01 22:54:322026-06N021411-005STRATTERAEQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2002-11-26a50c72e98297…
2026-08-01 22:54:322026-06N021411-006STRATTERAEQ 60MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2002-11-26a50c72e98297…
2026-08-01 22:54:322026-06N021411-007STRATTERAEQ 80MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2005-02-14a50c72e98297…
2026-08-01 22:54:322026-06N021411-008STRATTERAEQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE / ORALRLD2005-02-14a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
StratteraATOMOXETINE HYDROCHLORIDEEli Lilly and Company309de576-c318-404a-bc15-660c2b1876fb2026-06-30Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021411
application number: NDA021411

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0d16f546-db6a-1939-50fc-d06382424c97Product name420210903

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68151-4485-3Strattera1 in 1 PACKAGECAPSULE12

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68151-4485STRATTERA (ATOMOXETINE HYDROCHLORIDE) CAPSULE [CARILION MATERIALS MANAGEMENT]2Legacy NDC, 1 package rows20140820_b080e703-3fab-4914-8529-ffaa59da693d.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
349592atomoxetine HCl 18 MG Oral CapsulePSNb080e703-3fab-4914-8529-ffaa59da693d2
352318Strattera 18 MG Oral CapsulePSNb080e703-3fab-4914-8529-ffaa59da693d2
352318atomoxetine 18 MG Oral Capsule [Strattera]SBDb080e703-3fab-4914-8529-ffaa59da693d2
349592atomoxetine 18 MG Oral CapsuleSCDb080e703-3fab-4914-8529-ffaa59da693d2
349592atomoxetine 18 MG (as atomoxetine hydrochloride) Oral CapsuleSYb080e703-3fab-4914-8529-ffaa59da693d2
352318Strattera 18 MG Oral CapsuleSYb080e703-3fab-4914-8529-ffaa59da693d2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
68151-4485-3681514485031 in 1 PACKAGEHistorical